Close Menu

NEW YORK (GenomeWeb) – GenePOC announced today that its rapid molecular assay to detect group A Streptococcus has been granted clearance by the US Food and Drug Administration.

The test, which runs on GenePOC's Revogene instrument, is the third test from the Quebec City-based diagnostics developer to be FDA cleared. It uses throat swab samples and can report positive Strep A results in as little as 42 minutes, and negative results in 70 minutes without requirement for confirmation by bacterial culture, the firm said in a statement. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test. 

Apr
06
Sponsored by
Beckman Coulter

In this webinar session, Dr. David Harris and Dr. Ryan Sprissler, who led the student and employee testing program at University of Arizona, will discuss how the university has remained physically open with nearly 25 percent of its population on campus, while keeping infection rates below 2 percent.